Examinant per Autoria "Bellmunt Molins, Joaquim, 1959-"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)(Oxford University Press, 2017) Bellmunt Molins, Joaquim, 1959-; Kerst, Jan Martin; Vázquez, Francisca; Morales-Barrera, Rafael; Grande, Enrique; Medina, Ana; González Graguera, M.B.; Rubio, Gabriel; Anido, Urbano; Fernández Calvo, Ovidio; González-Billalabeitia, Enrique; Van den Eertwegh, Alfons Johannes M.; Pujol, E.; Perez-Gracia, Jose Luis; González Larriba, José Luis; Collado, R.; Los, Maartje; Maciá, Sonia; De Wit, R.; SOGUG; DUOS
Ítem Accés Obert A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: the future is now(Elsevier, 2017) Bellmunt Molins, Joaquim, 1959-; Powles, Thomas; Vogelzang, Nicholas J.
Ítem Accés Obert Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial(Elsevier, 2021) Bellmunt Molins, Joaquim, 1959-; IMvigor010 Study Group
Ítem Accés Obert Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice(Elsevier, 2021) Grivas, Petros; Agarwal, Neeraj; Pal, Sumanta; Kalebasty, Arash Rezazadeh; Sridhar, Srikala S.; Smith, Jodi; Devgan, Geeta; Sternberg, Cora N.; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial(Nature Research, 2021) Powles, Thomas; Sridhar, Srikala S.; Loriot, Yohann; Bellmunt Molins, Joaquim, 1959-; Mu, Xinmeng Jasmine; Ching, Keith A.; Pu, Jie; Sternberg, Cora N.; Petrylak, Daniel P.; Tambaro, Rosa; Dourthe, Louis M.; Alvarez-Fernandez, Carlos; Aarts, Maureen; Di Pietro, Alessandra; Grivas, Petros; Davis, Craig B.
Ítem Accés Obert Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(Elsevier, 2022) Powles, Thomas; Bellmunt Molins, Joaquim, 1959-; Comperat, E.; De Santis, Maria; Huddart, R.; Loriot, Yohann; Necchi, Andrea; Valderrama, Begoña P.; Ravaud, A.; Shariat, S.F.; Szabados, B.; van der Heijden, M.S.; Gillessen, S.; ESMO Guidelines Committee
Ítem Accés Obert Correlation of Apobec Mrna Expression with overall survival and pd-l1 expression in urothelial carcinoma(Nature Publishing Group, 2016) Mullane, Stephanie A.; Werner, Lillian; Rosenberg, Jonathan E.; Signoretti, Sabina; Callea, Marcella; Choueiri, Toni K.; Freeman, Gordon J.; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Corrigendum to 'EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort under the auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250](Elsevier, 2020) Witjes, J. Alfred; Bellmunt Molins, Joaquim, 1959-; Horwich, Alan
Ítem Accés Obert ctDNA guiding adjuvant immunotherapy in urothelial carcinoma(Nature Research, 2021) Powles, Thomas; Bellmunt Molins, Joaquim, 1959-; Mariathasan, Sanjeev
Ítem Accés Obert Efficacy of surgery in the primary tumor site for metastatic urothelial cancer: analysis of an international, multicenter, multidisciplinary database(Elsevier, 2020) Moschini, Marco; Xylinas, Evanguelos; Zamboni, Stefania; Mattei, Agostino; Niegisch, Günter; Yu, Evan Y.; Bamias, Aristotle; Agarwal, Neeraj; Sridhar, Srikala S.; Sternberg, Cora N.; Vaishampayan, Ulka N.; Rosenberg, Jonathan E.; Bellmunt Molins, Joaquim, 1959-; Galsky, Matthew D.; Montorsi, Francesco; Necchi, Andrea; RISC Investigators
Ítem Accés Obert Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study(BioMed Central, 2024) Cicin, Irfan; Plimack, Elizabeth R.; Gurney, Howard; Leibowitz, Raya; Alekseev, Boris Y.; Parnis, Francis X.; Peer, Avivit; Necchi, Andrea; Bellmunt Molins, Joaquim, 1959-; Nishiyama, Hiroyuki; Clark, Jason; Munteanu, Mihaela; Kataria, Ritesh; Jia, Calvin; Powles, Thomas; Sternberg, Cora N.
Ítem Accés Obert Epithelial-to-mesenchymal transition mediates resistance to maintenance therapy with vinflunine in advanced urothelial cell carcinoma(MDPI, 2021) Font, Albert; Ruiz de Porras, Vicenç; Valderrama, Begoña P.; Ramirez, Jose Luis; Nonell Mazelon, Lara, 1972-; Virizuela, José Antonio; Anido, Urbano; González-Del-Alba, Aránzazu; Lainez, Nuria; Llorente, Maria Del Mar; Jiménez, Natalia; Mellado, Begoña; García-Donas, Jesús; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma(Nature Research, 2018) Bellmunt Molins, Joaquim, 1959-; Lalani, Aly-Khan A.; Jacobus, Sussana; Mullane, Stephanie A.; Polacek, Laura; Takeda, David Y.; Harshman, Lauren C.; Wagle, Nikhil; Moreno, Irene; Lundgren, Kevin; Bossé, Dominick; Van Allen, Eliezer M.; Choueiri, Toni K.; Rosenberg, Jonathan E.
Ítem Accés Obert FORT-1: Phase II/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1/ 3 mRNA expression(American Society of Clinical Oncology, 2023) Sternberg, Cora N.; Bellmunt Molins, Joaquim, 1959-; Quinn, David I.
Ítem Accés Obert Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer(American Association for Cancer Research (AACR), 2020) Bellmunt Molins, Joaquim, 1959-; Perera Bel, Júlia; Orsola, Anna; Rodriguez-Vida, Alejo; Juanpere, Nuria; Lloreta, Josep, 1958-; Hernández, Silvia; Kwiatkowski, David J.
Ítem Accés Obert HER2 as a target in invasive urothelial carcinoma(Wiley, 2015) Bellmunt Molins, Joaquim, 1959-; Werner, Lillian; Bamias, Aristotle; Fay, André P.; Park, Rachel S.; Riester, Markus; Selvarajah, Shamini; Barletta, Justine A.; Berman, David M.; Muga, Silvia de; Salido, Marta; Gallardo, Enrique; Rojo, Federico; Guancial, Elizabeth A.; Bambury, Richard; Mullane, Stephanie A.; Choueiri, Toni K.; Loda, Massimo; Stack, Edward; Rosenberg, Jonathan E.
Ítem Accés Obert Identification of ALK gene alterations in urothelial carcinoma(Public Library of Science (PLoS), 2014) Bellmunt Molins, Joaquim, 1959-; Selvarajah, Shamini; Rodig, Scott; Salido Galeote, Marta; Muga, Silvia de; Costa, Irmgard; Bellosillo Paricio, Beatriz; Werner, Lillian; Mullane, Stephanie A.; Fay, André P.; O’Brien, Robert; Barretina, Jordi; Minoche, André E.; Signoretti, Sabina; Montagut Viladot, Clara; Himmelbauer, Heinz; Berman, David M.; Kantoff, Philip; Choueiri, Toni K.; Rosenberg, Jonathan E.
Ítem Accés Obert Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer(Springer, 2024) Segalés Tañà, Laura, 1994-; Juanpere, Nuria; Gallarín, Nerea; Lorenzo Perez, Marta; López Martos, David; Perera Bel, Júlia; Rodriguez-Vida, Alejo; Fumadó Ciutat, Lluis; Cecchini Rosell, Lluís; Bellmunt Molins, Joaquim, 1959-; Lloreta, Josep, 1958-; Hernández Llodrà, Silvia
Ítem Accés Obert Immunotherapy in non-metastatic urothelial cancer: back to the 'future'(Taylor & Francis, 2019) Darling, Harry S.; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial(Elsevier, 2017) García-Donas, Jesús; Bellmunt Molins, Joaquim, 1959-
- «
- 1 (current)
- 2
- 3
- »